"The US Food and Drug Administration (FDA) has approved a quarterly injection form of paliperidone (Invega Trinza, Janssen Pharmaceuticals) for schizophrenia, the company announced today.
Janssen Pharmaceuticals already markets a "...
INSTRUCTIONS FOR USE
(asenapine) Sublingual Tablets
Read these Instructions for Use before you start using SAPHRIS and each time you get a refill. There may be new information. This leaflet does not take the place of talking to your doctor about your medical condition or your treatment.
- For sublingual (under your tongue) use only
- Do not remove tablet until ready to administer.
- Use dry hands when handling tablet.
Your SAPHRIS tablets
Directions for Taking your SAPHRIS Tablets:
Step 1. Firmly press and hold thumb button, then pull out the tablet pack (see Figure A). Do not push tablet through the tablet pack. Do not cut or tear the tablet pack.
Step 2. Peel back the colored tab (see Figure B).
Step 3. Gently remove the tablet (see Figure C). Do not split, cut or crush the tablet.
Step 4. Place the whole tablet under tongue and allow it to dissolve completely (see Figure D).
Do not chew or swallow the tablet.
Do not eat or drink for 10 minutes (See Figure E).
Step 5. Slide the tablet pack back into case until it clicks (see Figure F).
Storing SAPHRIS tablets:
Store SAPHRIS tablets at room temperature between 68°F to 77°F (20°C to 25°C).
These Instructions for Use have been approved by the U.S. Food and Drug Administration.
Last reviewed on RxList: 3/26/2015
This monograph has been modified to include the generic and brand name in many instances.
Additional Saphris Information
Saphris - User Reviews
Saphris User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
Get tips on therapy and treatment.